We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By continuing to use the website, you consent to our use of cookies. Close

ERS Genomics secures EPO CRISPR victory

Intellectual Property Magazine

ERS Genomics secures EPO CRISPR victory

ERS Genomics has successfully defended one of its EU patents covering CRISPR-Cas9 gene editing technologies, after the European Patent Office (EPO) rejected arguments filed in opposition to the patent.

The rest of this document is only available to i-law.com online subscribers.

If you are already a subscriber, please enter your details below to log in.

Enter your email address to log in as a user on your corporate account.
Remember me on this computer

Not yet an i-law subscriber?


Request a trial Find out more